Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ABEO — Abeona Therapeutics Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$226,113
+$151,290 QoQ
Shares Held
36,588
+119.1% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 125 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ABEO ranks #242 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ABEO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $226,113 36,588
2026-03-31 $74,823 16,702
2025-12-31 $252,179 47,852
2025-09-30 $143,504 27,179
2025-06-30 $129,844 22,860
2024-09-30 $379 60
2024-06-30 $254 60
2024-03-31 $1,769 244
2023-12-31 $1,186 237
2023-09-30 $707 168
2023-06-30 $515 128
2023-03-31 $318 113
2022-12-31 $150 49
2022-09-30 $106 35
2022-06-30 $206 987
2022-03-31 $289 907
2021-12-31 $212 625
2021-09-30 $698 624
2021-06-30 $701 450
2021-03-31 $41,865 22,269
2020-12-31 $127,078 80,942
2020-09-30 $65,049 63,774
2020-06-30 $223,645 76,591
2020-03-31 $99,250 47,262